Effect of a 21-Gene RT-PCR Assay on Treatment Recommendations for Patients with Node-Positive, ER-Positive Breast Cancer
Slides from a presentation at SABCS 2009 and transcribed comments from a recent interview
with Adam M Brufsky, MD, PhD (12/23/09)
Dr Brufsky is Associate Professor of Medicine and Associate Division Chief of Hematology/Oncology at the University of Pittsburgh, Co-Director of the Comprehensive Breast Cancer Center and Associate Director for Clinical Investigation at the University of Pittsburgh Cancer Institute in Pittsburgh, Pennsylvania.
Presentation discussed in this issue:
Oratz R et al. Effect of 21-gene recurrence score results on treatment recommendations in patients with lymph node-positive, estrogen receptor-positive breast cancer. San Antonio Breast Cancer Symposium 2009;Abstract 2031.
Go to previous Journal Club Go to next Journal Club